Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00655863n
Noun Concept
Categories: Breakthrough therapy, Orphan drugs, Thrombopoietin receptor agonists, Hydrazines, Drugs acting on the blood and blood forming organs
EN
eltrombopag  3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid  Alvaiz  AMG531  ATC code B02BX05
EN
Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia and severe aplastic anemia. Wikipedia
Definitions
Relations
Sources
EN
Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia and severe aplastic anemia. Wikipedia
Chemical compound Wikidata
A drug to treat conditions that lead to thrombocytopenia. Wiktionary
IS A
carboxylic acid
compound
medicine
MEDICAL CONDITION TREATED
anemia
thrombocytopenia
myelodysplastic syndrome
PREGNANCY CATEGORY
Australian pregnancy category B3
Wikipedia
EN
eltrombopag
Wikidata
EN
eltrombopag
Wiktionary
EN
eltrombopag
Wikipedia Redirections
EN
Alvaiz, ATC code B02BX05, ATCvet code QB02BX05, Elbonix, Eltrombopag olamine, Promacta, Promacta Kit, Revolade
Wikidata Alias
EN
AMG531, ETB115, SB-497115-GR, 3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License